Teamwork Financial Advisors LLC Sells 25,886 Shares of Colgate-Palmolive (NYSE:CL)

Teamwork Financial Advisors LLC decreased its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 83.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,183 shares of the company’s stock after selling 25,886 shares during the period. Teamwork Financial Advisors LLC’s holdings in Colgate-Palmolive were worth $471,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. Wesbanco Bank Inc. lifted its position in Colgate-Palmolive by 1.7% during the fourth quarter. Wesbanco Bank Inc. now owns 15,066 shares of the company’s stock worth $1,370,000 after acquiring an additional 250 shares during the last quarter. Janney Montgomery Scott LLC grew its stake in shares of Colgate-Palmolive by 2.2% in the fourth quarter. Janney Montgomery Scott LLC now owns 387,487 shares of the company’s stock valued at $35,227,000 after acquiring an additional 8,293 shares in the last quarter. Atomi Financial Group Inc. increased its position in Colgate-Palmolive by 6.5% during the fourth quarter. Atomi Financial Group Inc. now owns 6,489 shares of the company’s stock worth $590,000 after acquiring an additional 394 shares during the period. Crossmark Global Holdings Inc. boosted its holdings in Colgate-Palmolive by 4.3% in the 4th quarter. Crossmark Global Holdings Inc. now owns 173,831 shares of the company’s stock valued at $15,803,000 after purchasing an additional 7,105 shares during the period. Finally, Ballentine Partners LLC boosted its stake in shares of Colgate-Palmolive by 2.2% in the fourth quarter. Ballentine Partners LLC now owns 21,007 shares of the company’s stock valued at $1,910,000 after buying an additional 460 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CL has been the topic of several analyst reports. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a report on Thursday, January 16th. UBS Group decreased their price target on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. Barclays reduced their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Piper Sandler decreased their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. Finally, StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Hold” and an average target price of $101.11.

View Our Latest Analysis on Colgate-Palmolive

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Trading Down 0.8 %

Shares of CL opened at $87.53 on Thursday. The firm has a market cap of $71.51 billion, a P/E ratio of 25.08, a price-to-earnings-growth ratio of 3.62 and a beta of 0.44. Colgate-Palmolive has a fifty-two week low of $80.03 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The business has a 50-day moving average of $92.00 and a 200 day moving average of $97.58.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.28%. Colgate-Palmolive’s dividend payout ratio is 57.31%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.